✦ LIBER ✦

Designing clinical trials for early (pre-dementia) Alzheimer’s disease: Determining the appropriate population for treatment

✍ Scribed by E. Siemers

Publisher: Springer
Year: 2011
Tongue: English
Weight: 59 KB
Volume: 15
Category: Article
ISSN: 1279-7707
DOI: 10.1007/s12603-011-0008-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials for early (pre-dementia)

Clinical trials for early (pre-dementia) Alzheimer’s disease: A case for mild cognitive impairment

✍ R. C. Petersen 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 42 KB

Evolving early (pre-dementia) Alzheimer’

Evolving early (pre-dementia) Alzheimer’s disease trials: Suit the outcomes to the population and study design

✍ R. S. Doody 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 69 KB

The potential and limits for clinical tr

The potential and limits for clinical trials for early Alzheimer’s disease and some recommendations

✍ L. S. Schneider 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 70 KB

Review of donepezil, rivastigmine, galan

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population

✍ V. P. Prasher 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract The management of dementia in Alzheimer's disease has dramatically changed since the development of anti‐dementia drugs. However, there is limited information available regarding the bio‐medical aspects of the differing drugs; particularly relating to adults with intellectual disability